Dataset Information

Peptide analysis in human cell lines via high-resolution MRM (PRM) for the annotation of non-canonical open reading frames

ABSTRACT: A major scientific drive is to characterize the protein-coding genome, which is a primary basis for studying human health. But the fundamental question remains: what has been missed in prior analyses? Over the past decade, the translation of non-canonical open reading frames (ncORFs) has been observed across human cell types and disease states, with major implications for proteomics, genomics, and clinical science. However, the impact of ncORFs has been limited by the absence of a generalized understanding of their contribution to the human proteome. Here, we report the collaborative efforts of stakeholders in proteomics, immunopeptidomics, ORF discovery, and gene annotation to produce a consensus landscape of protein-level evidence for ncORFs. We show that at least 25% of a set of 7,264 ncORFs give rise to translated gene products detected in a large-scale analysis encompassing 3.8 billion mass spectra from 95,520 experiments. With these data, we developed an annotation framework for ncORFs and codified public tools for researchers through GENCODE and PeptideAtlas. To probe the biological implications of ncORFs, we created a custom evolutionary analysis approach, termed ORF Relative Branch Length (ORBL), and found that a substantial fraction of ncORFs exhibit evolutionary constraint as open reading frames, which associates with the chance of observing ncORF-derived peptides. To classify such cases, we invoked the model of “peptideins” as a new protein annotation concept referring to ncORF-derived polypeptides that fall short of the definition of a conventional protein. We then employed knockout screens of putative peptideins and characterized one ncORF from the OLMALINC transcript as responsible for a pan-essential cellular phenotype. Overall, our work will provide a platform to advance ncORF-derived proteins in biomedical discovery and, beyond humans, diverse animals and plants where ncORFs are similarly observed.We demonstrated that ncORF peptides are detectable in human cell lysates using targeted mass spectrometry and heavy labeled synthetic peptides. Data were acquired with a ZenoTOF 8600 as well as an Orbitrap Astral mass spectrometer.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture

SUBMITTER: Ulrike Kusebauch

LAB HEAD: Robert Moritz.

PROVIDER: PXD066599 | Pride | 2026-02-17

REPOSITORIES: Pride

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	0712_S005_90min_250ng_HeLaS3_Pr2P2_6fmol_iRT_nc240_01.timeseries.data	Other
	0712_S005_90min_250ng_HeLaS3_Pr2P2_6fmol_iRT_nc240_01.wiff	Wiff
	0712_S005_90min_250ng_HeLaS3_Pr2P2_6fmol_iRT_nc240_01.wiff.scan	Wiff
	0712_S005_90min_250ng_HeLaS3_Pr2P2_6fmol_iRT_nc240_01.wiff2	Wiff
	0712_S006_90min_250ng_Hek293_Pr2P2_6fmol_iRT_nc240_01.timeseries.data	Other

Items per page:

1 - 5 of 28

Publications

Expanding the human proteome with microproteins and peptideins.

Deutsch Eric W EW Kok Leron W LW Mudge Jonathan M JM Valls Cristian F CF Jungreis Irwin I Ruiz-Orera Jorge J Sun Zhi Z Kusebauch Ulrike U Fierro-Monti Ivo I Abelin Jennifer G JG Alba M Mar MM Aspden Julie L JL Bandyopadhyay Sreejan S Banerjee Kaushik K Baranov Pavel V PV Bazzini Ariel A AA Bourassa Francis F Bruford Elspeth A EA Calviello Lorenzo L Carr Steven A SA Carvunis Anne-Ruxandra AR Chothani Sonia S Clauwaert Jim J Dean Kellie K Faridi Pouya P Frankish Adam A Goodale Amy A Green Thomas T Hubner Norbert N Ingolia Nicholas T NT Kellis Manolis M Magrane Michele M Martin Maria Jesus MJ Martinez Thomas F TF Menschaert Gerben G Ohler Uwe U Orchard Sandra S Potter Alisa A Rackham Owen J L OJL Rees Matthew G MG Root David E DE Roth Jennifer A JA Roucou Xavier X Sialana Fernando J FJ Slavoff Sarah A SA Świrski Michał I MI Tierney Jack A S JAS Trifiro Félix-Antoine FA Valen Eivind E Vasylieva Valeriia V Wacholder Aaron A Wang Shengbo S Wang Li L Weissman Jonathan S JS Wu Wei W Xie Zhi Z Choudhary Jyoti S JS Bassani-Sternberg Michal M Vizcaíno Juan Antonio JA Ternette Nicola N Brunet Marie A MA Moritz Robert L RL Prensner John R JR van Heesch Sebastiaan S

Nature 20260506 8119

A major scientific drive is to characterize the protein-coding genome, which is a primary basis for studying human health. But the fundamental question remains of what has been missed in previous analyses. Over the past decade, the translation of non-canonical open reading frames (ncORFs) has been observed across human cell types and disease states<sup>1-3</sup>, with major implications for biomedical science. However, a key gap in knowledge has been which ncORFs produce small microproteins or a ...[more]

PMID: 42092140

Similar Datasets

Project description:MicroRNAs (miRNAs) have been shown to play an important role in many different cellular, developmental, and physiological processes. Accordingly, numerous methods have been established to identify and quantify miRNAs. The shortness of miRNA sequence results in a high dynamic range of melting temperatures and, moreover, impedes a proper selection of detection probes or optimized PCR primers. While miRNA microarrays allow for massive parallel and accurate relative measurement of all known miRNAs, they have so far been less useful as an assay for absolute quantification. Here, we present a microarray based approach for global and absolute quantification of miRNAs. The method relies on an equimolar pool of about 1000 synthetic miRNAs of known concentration which is used as an universal reference and labeled and hybridized in a dual colour approach on the same array as the sample of interest. Each single miRNA is quantified with respect to the universal reference outbalancing bias related to sequence, labeling, hybridization or signal detection method. We demonstrate the accuracy of the method by various spike in experiments. Further, we quantified miRNA copy numbers in liver samples and CD34(+)CD133(-) hematopoietic stem cells. The RNA extracted from 7 x 10^ 5 to 1 x 10^ 6 CD34(+)/CD133(-) cells of three different donors was analyzed. 1 µg of respective total RNA was mixed with 2.5 fmol of each of 18 RNA oligonucleotides reverse complement to miRControl 3 probes and subsequently fluorescently labelled by 3’ ligation. Total RNA mix was hybridized in a dual colour approach to microarrays versus a second labelled synthetic miRNA pool. The synthetic miRNA pool consisted of 2.5 fmol of each of 954 non redundant miRNAs sequences and miRControl 3 sequences. The array data was normalized by calculating the median of the miRControl 3 present in the CD34(+)/CD133(-) and UR sample. The miRNA amount was calculated with respect to the corresponding miRNA in the UR.

Project description:MicroRNAs (miRNAs) have been shown to play an important role in many different cellular, developmental, and physiological processes. Accordingly, numerous methods have been established to identify and quantify miRNAs. The shortness of miRNA sequence results in a high dynamic range of melting temperatures and, moreover, impedes a proper selection of detection probes or optimized PCR primers. While miRNA microarrays allow for massive parallel and accurate relative measurement of all known miRNAs, they have so far been less useful as an assay for absolute quantification. Here, we present a microarray based approach for global and absolute quantification of miRNAs. The method relies on an equimolar pool of about 1000 synthetic miRNAs of known concentration which is used as an universal reference and labeled and hybridized in a dual colour approach on the same array as the sample of interest. Each single miRNA is quantified with respect to the universal reference outbalancing bias related to sequence, labeling, hybridization or signal detection method. We demonstrate the accuracy of the method by various spike in experiments. Further, we quantified miRNA copy numbers in liver samples and CD34(+)CD133(-) hematopoietic stem cells. We analyzed to which extend the universal reference can be used as a tool for the relative quantification of miRNAs across multiple experiments. We compared the results of direct hybridizations i.e. sample vs. sample to those of indirect hybridizations i.e. sample vs. UR. For the direct hybridizations, we hybridized 5Âµg liver total RNA vs 5 Âµg brain total RNA (n = 3) and for the indirect hybridization 5 Âµg liver or brain total RNA vs UR (5 fmol/miRNA) (n = 3). We calculated the so-called re-ratios for the UR experiments by dividing the signal ratios of the liver vs. UR array by the respective brain vs. UR array gaining a liver vs. brain re-ratio. Each RNA sample was mixed with 5 fmol of each of 18 RNA oligonucleotides reverse complement to miRControl 3 probes and subsequently fluorescently labelled. The RNA mix was hybridized in a dual colour approach to microarrays. The mean ratios of all probes were normalized to the median of the ratios detected for the spiked 18 synthetic RNA oligonucleotides reverse complement to miRControl 3 probes.

Project description:Heart failure is associated with high morbidity and mortality and its incidence increases worldwide. MicroRNAs (miRNAs) are potential markers and targets for diagnostic and therapeutic applications, respectively. We determined myocardial and circulating miRNA abundance and its changes in patients with stable and end-stage heart failure before and at different time points after mechanical unloading by a left ventricular assist device (LVAD) by small-RNA-sequencing. MiRNA changes in failing heart tissues partially resembled that of fetal myocardium. Consistent with prototypical miRNAM-bM-^@M-^Starget-mRNA interactions, target mRNA levels were negatively correlated to changes in abundance for highly expressed miRNAs in heart failure and fetal hearts. The circulating small RNA profile was dominated by miRNAs, and fragments of tRNAs and small cytoplasmic RNAs. Heart- and muscle-specific circulating miRNAs (myomirs) increased up to 140-fold in advanced heart failure, which coincided with a similar increase in cardiac troponin I protein, the established marker for heart injury. These extracellular changes nearly completely reversed 3 months following initiation of LVAD support. In stable heart failure, circulating miRNAs showed less than 5-fold differences compared to normal, and myomir and cardiac troponin I levels were only captured near the detection limit. These findings provide the underpinning for miRNA-based therapies and emphasize the usefulness of circulating miRNAs as biomarkers for heart injury performing similar to established diagnostic protein biomarkers. Total RNA isolated from human left ventricular myocardium of failing hearts due to dilated or ischemic cardiomyopathy before and after mechanical unloading by a left ventricular assist device, and fetal myocardium compared to non-failing postnatal myocardium was subjected to multiplexed small RNA-sequencing on the Illumina platform. mRNA gene expression data using Illumina HumanHT-12v4 beadarrays for a subset of the myocardial samples is available (GSE52601).

Project description:MicroRNAs (miRNAs) have been shown to play an important role in many different cellular, developmental, and physiological processes. Accordingly, numerous methods have been established to identify and quantify miRNAs. The shortness of miRNA sequence results in a high dynamic range of melting temperatures and, moreover, impedes a proper selection of detection probes or optimized PCR primers. While miRNA microarrays allow for massive parallel and accurate relative measurement of all known miRNAs, they have so far been less useful as an assay for absolute quantification. Here, we present a microarray based approach for global and absolute quantification of miRNAs. The method relies on an equimolar pool of about 1000 synthetic miRNAs of known concentration which is used as an universal reference and labeled and hybridized in a dual colour approach on the same array as the sample of interest. Each single miRNA is quantified with respect to the universal reference outbalancing bias related to sequence, labeling, hybridization or signal detection method. We demonstrate the accuracy of the method by various spike in experiments. Further, we quantified miRNA copy numbers in liver samples and CD34(+)CD133(-) hematopoietic stem cells. Different probe designs were investigated with respect to sensitivity and selectivity of microarray hybridization. An array with 11 different variants of oligonucleotides for miR-122a and miR-16 was produced. 5 µg of respective total RNA was fluorescently labelled by 3’ ligation. Total RNA was hybridized in a dual colour approach to microarrays versus a second labelled synthetic miRNA pool. The synthetic miRNA pool consisted of 5 fmol of each of 816 non redundant miRNAs sequences and miRControl 3 sequences. Local background was subtracted from the signal to obtain the net signal intensity and the mean of the net signal intensities of 4 corresponding spots representing the same miRNA was computed for those spots only which were unflagged (empty spots, poor spots, negative spots) and for which the fluorescent intensity of the miRNAs derived from the samples of interest was two-fold the mean background value (2bkg dataset).